GSK investigational vaccine GSK2340272A

BIOLOGICAL6 trials

Sponsors

GlaxoSmithKline

Conditions

Influenza

Phase 2

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

CompletedNCT00951041

GlaxoSmithKlineInfluenza

Start: 2009-08-11End: 2010-08-30Updated: 2018-11-26

Phase 3

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

CompletedNCT00968539

GlaxoSmithKlineInfluenza

Start: 2009-09-08End: 2010-09-28Updated: 2019-11-18

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

CompletedNCT00968526

GlaxoSmithKlineInfluenza

Start: 2009-09-08End: 2010-09-23Updated: 2019-06-25

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

CompletedNCT00972517

GlaxoSmithKlineInfluenza

Start: 2009-09-29End: 2010-11-22Updated: 2019-06-26

Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

CompletedNCT00975884

GlaxoSmithKlineInfluenza

Start: 2009-09-14End: 2010-04-30Updated: 2019-03-18

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes

CompletedNCT00992511

GlaxoSmithKlineInfluenza

Start: 2009-10-14End: 2010-11-09Updated: 2019-01-31

Related Papers

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials

Clinical and Vaccine Immunology2017-04-2718 citations

Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.

2013-04-0910 citations

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

2012-07-233 citations

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

2010-09-0179 citations